FLABRA: Frontline approach for BRCA testing in OC treatment naïve population. A LATIN AMERICA Epidemiologic Study

Trial Identifier: D0817R00002
Sponsor: AstraZeneca
NCTID:: NCT02984423
Start Date: December 2016
Primary Completion Date: June 2019
Study Completion Date: June 2019
Condition: Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Argentina Buenos Aires, Argentina, C1118AAT
Argentina Buenos Aires, Argentina, C1025ABI
Argentina Buenos Aires, Argentina, C1431FWO
Argentina CABA, Argentina, C1426ANZ
Argentina Cordoba, Argentina, 5000
Argentina La Rioja, Argentina, 5300
Argentina Resistencia, Argentina, 3500
Argentina Rosario, Argentina, S2000KZE
Brazil Barretos, Brazil, 14784-400
Brazil Belo Horizonte, Brazil, 30130-100
Brazil Belo Horizonte, Brazil, 30380-472
Brazil Curitiba, Brazil, 81520-060
Brazil Fortaleza, Brazil, 60430-230
Brazil Fortaleza, Brazil, 60336-045
Brazil Jaú, Brazil, 17210-120
Brazil Passo Fundo, Brazil, 99010 260
Brazil Porto Alegre, Brazil, 90610-000
Brazil Rio de Janeiro, Brazil, 20560-120
Brazil Rio de Janeiro, Brazil, 22793-080
Brazil Salvador, Brazil, 41950-610
Brazil Sao Paulo, Brazil, 01246-000
Brazil Sao Paulo, Brazil, 05651-901
Brazil São Paulo, Brazil, 01317-000
Brazil São Paulo, Brazil, 01308-050
Colombia Bogota, Colombia
Colombia Bogotá, Colombia
Colombia Cali, Colombia
Colombia Medellín, Colombia
Mexico México, Mexico, 1400
Panama Ciudad de Panama, Panama
Peru lima, Peru, 0051
Peru Lima, Peru, LIMA 11
Peru Lima, Peru, LIMA 13
Peru San Isidro, Peru